ImExHS (IME.AX) Stock Price

ImExHS Price

ASX·CLOSED
0.32
​
Market closed

Over the last 19 years ImExHS grew revenue by 2.5% annually, reaching 28.97 M AUD. For ImExHS, the net margin of -9.9% is up versus -35.1% a few years ago. The consensus 12-month price target for ImExHS is 0.36 AUD, about 9.8% above where the stock trades today. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.

ImExHS stock price

Access this data via the Eulerpool API

ImExHS business model & stock analysis

ImExHS Ltd. engages in the development and sale of its Hiruko software platform. The company is headquartered in Mascot, New South Wales and currently employs 300 full-time employees. The company went IPO on 2005-12-14. The firm operates two businesses, namely medical imaging software and radiology services. The medical imaging software business is focused on the development and sale of modular cloud-based imaging systems that include information systems for radiology, pathology and other ologies. The main component of the software is a Picture Archiving and Communications System (PACS), with a Web viewer. The information systems combine a workflow management system (RIS) with a patient data and image distribution system (Patient Portal), and the PACS allows a healthcare organization to capture, store, view and share radiology images. The radiology services business provides radiological diagnostic services to hospitals and medical facilities in Colombia and Spain using IMEXHS medical imaging software. The radiology services business also provides medical images and radiologists interpretation and reports to develop artificial intelligence (AI) tools.

Frequently asked questions about ImExHS

Analysts currently set an average price target of 0.36 AUD for the ImExHS stock (median: 0.36 AUD), implying +9.8 % versus the latest price. The consensus is based on 5 analyst ratings.

5 analysts currently rate the ImExHS stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect ImExHS to generate revenue of 32.85 M AUD and earnings per share of -0.00 AUD.

Converted at the current exchange rate, the ImExHS share trades at 0.20 EUR (0.32 AUD).

The ImExHS share (IME.AX) is listed on 1 stock exchanges, including: ASX (IME.AX).

The expected revenue of ImExHS is 32.85 M AUD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of ImExHS is -10,810.00 AUD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of ImExHS is currently -1,625.02. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the ImExHS stock.

The price-to-sales ratio (P/S) of ImExHS is currently 0.53. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the ImExHS stock.

The Eulerpool Quality Score for ImExHS is 4/10.

The ISIN of ImExHS is AU0000023053. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of ImExHS is IME.AX. The ticker symbol is used to trade ImExHS shares on the stock exchange.

Fair ValueTerminal
0.27 AUD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Technology
Number of shares
Employees
Revenue per Employee
96,566.86 AUD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Australia
Currency
AUD
Initial public offering
Dec 14, 2005
ISIN
AU0000023053
Cusip
Q4857V109
Market capitalization
17.57 M AUDMicro Cap
52-Week Range
Revenue growth (10Y) > 5%
Revenue growth (3Y) > 5 %
EBIT growth (10Y) > 5%
EBIT growth (3Y) > 5 %
Net debt < 4x EBIT
Profitable since 10Y+
EBIT Drawdown (10Y) < 50%
Return on Equity (ROE) > 15%
ROCE > 15%
Return Expectation > 10%
PEG
—
P/E ratio
P/Ee 2026
-1,625.02
P/Ee 2027
45.77
P/Ee 2028
3.35
P/S
P/Se
0.53
EV/EBIT
—
P/B Ratio
1.11
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-17.54 %
Gross Margin
28.69 %
EBIT Margin
-2.41 %
Net Margin
-9.95 %
EPS (Earnings Per Share)
-0.05 AUD
Net Debt / EBIT
3.92
Debt/Equity
0.04
Last updated Oct 5, 2026, 2:30 PM

ImExHS Peer Group

ImExHS Ticker

ASX · IME.AX

ImExHS FIGI

IME:AU · BBG000BS84K6IME:AT · BBG000BS85D1IME:AH · BBG002F3JLF9OMTEUR:EO · BBG009Q074G8OMTEUR:XH · BBG009Q074K3OMTEUR:XF · BBG009Q074M1OMTEUR:XE · BBG009Q074P8OMTEUR:XJ · BBG009Q074Q7OMTEUR:XL · BBG009Q074R6OMTEUR:XG · BBG009Q074S5OMTEUR:XO · BBG009Q074T4OMTEUR:XS · BBG009Q074Y8

All fundamentals and in-depth analysis of ImExHS

Our stock analysis for ImExHS stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ImExHS. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.